Santhera Pharmaceuticals (0QN1.LSE) Q3 2024 Earnings

12SepConfirmed
Q1 2023
Q2 2023
Q2 2024
Q3 2024
-1.28
-0.85
-0.43
0

Details

Expected EPS
N/A
Actual EPS
-1.2764243142
Surprise EPS
-1.28
Surprise Percent
+∞%

Description

Santhera Pharmaceuticals (0QN1.LSE) has reported earnings of -1.2764243142 per share for Q3 2024.

0 Comments

Share your thoughts